02257.HK
Sirnaomics Ltd.
HKSE · Healthcare · Biotechnology · HK
HKD 3.80
−3.55%Margins
Gross margin
-124.5%
EBITDA margin
-2937.3%
EBIT margin
-3448.2%
Net margin
-2597.5%
FCF margin
-1935.0%
406.6%
Return on equity
-183.8%
Return on assets
-170.5%
Return on invested capital
0.06x
Asset turnover
-HKD 143.9M
Cash from operations
HKD 0.60
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026